| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |